0001243786-22-000125.txt : 20220527
0001243786-22-000125.hdr.sgml : 20220527
20220527173752
ACCESSION NUMBER: 0001243786-22-000125
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220427
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Rourke James Calvin
CENTRAL INDEX KEY: 0001453221
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32327
FILM NUMBER: 22979305
MAIL ADDRESS:
STREET 1: C/O THE MOSAIC COMPANY
STREET 2: 101 EAST KENNEDY BLVD., SUITE 2500
CITY: TAMPA
STATE: FL
ZIP: 33602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOSAIC CO
CENTRAL INDEX KEY: 0001285785
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870]
IRS NUMBER: 201026454
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 EAST KENNEDY BLVD.
STREET 2: SUITE 2500
CITY: TAMPA
STATE: FL
ZIP: 33602
BUSINESS PHONE: 813-775-4200
MAIL ADDRESS:
STREET 1: 101 EAST KENNEDY BLVD.
STREET 2: SUITE 2500
CITY: TAMPA
STATE: FL
ZIP: 33602
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL NUTRITION SOLUTIONS INC
DATE OF NAME CHANGE: 20040401
4
1
wf-form4_165368745615297.xml
FORM 4
X0306
4
2022-04-27
0
0001285785
MOSAIC CO
MOS
0001453221
O'Rourke James Calvin
C/O THE MOSAIC COMPANY
101 EAST KENNEDY BLVD., SUITE 2500
TAMPA
FL
33602
1
1
0
0
President & CEO
Common Stock
2022-04-27
5
G
0
E
13295
0
D
0
I
By 2019 GRAT dated April 1, 2019
Common Stock
2022-04-27
5
G
0
E
13295
0
A
148515
D
Common Stock
2022-05-25
5
G
0
E
143742
0
D
0
I
By 2020 GRAT dated May 21, 2020
Common Stock
2022-05-25
5
G
0
E
25672
0
A
174187
D
Common Stock
2022-05-25
5
G
0
E
174187
0
D
0
D
Common Stock
2022-05-25
5
G
0
E
174187
0
A
174187
I
2022 GRAT 2A dated April 22, 2022
Common Stock
130294
I
By 2021 GRAT 2 dated June 30, 2021
Common Stock
23128
I
By 2021 GRAT 3 dated June 30, 2021
Common Stock
3000
I
Reporting Person's Spouse
Stock Option (Right to Buy)
54.03
2023-07-18
Common Stock
29987.0
29987
D
Stock Option (Right to Buy)
49.73
2024-03-07
Common Stock
33706.0
33706
D
Stock Option (Right to Buy)
50.43
2025-03-05
Common Stock
37306.0
37306
D
Stock Option (Right to Buy)
28.49
2026-03-03
Common Stock
179211.0
179211
D
Stock Option (Right to Buy)
30.42
2027-03-02
Common Stock
168180.0
168180
D
Restricted Stock Units
0.0
2023-03-05
Common Stock
121989.0
121989
D
Restricted Stock Units
0.0
2024-03-04
Common Stock
83418.0
83418
D
Restricted Stock Units
0.0
2025-03-03
Common Stock
56773.0
56773
D
On April 27, 2022, the reporting person indirectly held 13,295 shares of MOS common stock ("2019 GRAT Shares") in a grantor retained annuity trust for the benefit of himself and his spouse ("2019 GRAT"). On that date and upon termination of the 2019 GRAT, the 2019 GRAT Shares were distributed to the reporting person in satisfaction of an annuity due to the reporting person and was exempt from reporting under Rule 16a-13.
On May 25, 2022, the reporting person indirectly held 143,742 shares of MOS common stock ("2020 GRAT Shares") in a grantor retained annuity trust for the benefit of himself and his spouse ("2020 GRAT"). On that date and upon termination of the 2020 GRAT, 118,070 of the 2020 GRAT Shares were distributed to the James C. O'Rourke Grantor Investment Trust of 2019 for the benefit of the reporting person's adult children, which distribution was exempt from reporting under rule 16b-5; and 25,672 of the 2020 GRAT Shares shares were distributed to the reporting person in satisfaction of an annuity due to the reporting person and was exempt from reporting under Rule 16a-13.
This transaction involved a gift of MOS common stock by the reporting person to a grantor retained annuity trust dated April 22, 2022, for the benefit of reporting person and his spouse ("2022 GRAT 2A"). The reporting person serves as trustee of the 2022 GRAT 2A.
This Stock Option is 100% exercisable.
One-for-One
Not Applicable
/s/ Mark J. Isaacson, Attorney-in-Fact for James C. O'Rourke
2022-05-27